Disease Prevention Asundexian Reduces Risk of Future Ischemic Stroke as Secondary Prevention admin December 15, 2025 0 In the phase 3 OCEANIC-STROKE study (NCT05686070), asundexian (Bayer), an investigational, once-daily,...Read More
